Two years after acquiring diagnostic developer SynX, Nanogen is on the verge of launching its first product based on that company's work: a point-of-care test for diagnosing congestive heart failure.
Two years after acquiring diagnostic developer SynX, Nanogen is on the verge of launching its first product based on that company's work: a point-of-care test for diagnosing congestive heart failure.
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.